e 64 has been researched along with Carcinoma, Squamous Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebert, W; Jülke, B; Lah, T; Spiess, E; Werle, B | 1 |
| Gorelik, E; Jani, JP; Lazo, JS; Mistry, JS; Sebti, SM | 1 |
| Jani, JP; Lazo, JS; Mistry, JS; Morris, G; Sebti, SM | 1 |
3 other study(ies) available for e 64 and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Cathepsin B fraction active at physiological pH of 7.5 is of prognostic significance in squamous cell carcinoma of human lung.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cathepsin B; Cysteine Proteinase Inhibitors; Dipeptides; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Leucine; Lung; Lung Neoplasms; Middle Aged; Prognosis; Substrate Specificity; Survival Analysis | 1997 |
Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
Topics: Animals; Bleomycin; Burkitt Lymphoma; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; DNA Damage; Drug Resistance; Glycoside Hydrolases; Head and Neck Neoplasms; Humans; Inactivation, Metabolic; Leucine; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured | 1991 |
Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
Topics: Bleomycin; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Cysteine Proteinase Inhibitors; Drug Resistance; Drug Synergism; Head and Neck Neoplasms; Leucine; Leupeptins; Tumor Cells, Cultured | 1991 |